NAD+ was identified in 1906 as a fermentation component; a century later it is a central molecule of aging research.
| Year | Stage |
|---|---|
| 1906 | Harden and Young: the yeast-fermentation 'co-enzyme' |
| 1930s | Warburg: role in redox reactions |
| 2000s | Sirtuins: NAD+ as deacetylase cofactor (Guarente, Sinclair) |
| 2010s | Age-dependent NAD+ decline; NMN/NR precursors in studies |
| 2020s | Wave of clinical and research interest; parenteral formats |
Three factors: measurable age-related NAD+ decline as a biomarker; sirtuin research with prominent names; the NMN/NR precursor market creating demand for NAD+ itself.
Mechanics — sibling explainer · dossier — NAD+.
1906 — as a fermentation 'co-enzyme'; the modern wave dates to the 2000s.
Precursor vs coenzyme: different material categories.